| (210) | Number of the EPO application | 16780921 |
| (220) | Filing date of the EPO application | 2016.04.26 |
| (80) | EPO patent specification publication (B) | EPB nr. 03/2021, 2021.01.20 |
| (110) | EPO patent number | 3283463 |
| (21) | Number of the application | e 2018 0195 |
| (71) | Name(s) of applicant(s), code of the country | The Trustees of The University of Pennsylvania, US; |
| (72) | Name(s) of inventor(s), code of the country | AMARAVADI Ravi K., US;
WINKLER Jeffrey, US; |
| (73) | Name(s) of owner(s), code of the country | THE Trustees of The University of Pennsylvania, US; |
| (54) | Title of the invention | DIMERIC QUINACRINE DERIVATIVES AS AUTOPHAGY INHIBITORS FOR CANCER THERAPY |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 219/12 (2006.01.01); A61K 31/473 (2006.01.01); A61P 35/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.04.30 |
| (30) | Priority | 201562148804 P, 2015.04.17, US |
| (86) | International application | PCT/US2016/027920, 2016.04.26 |
| (87) | International publication | WO 2016/168721, 2016.10.20 |